Kura Oncology Inc header image

Kura Oncology Inc

KURA

Equity

ISIN null / Valor 28160920

NASDAQ (2026-04-27)
USD 9.07-2.05%

Kura Oncology Inc
UMushroom community rating:

star star star star star
3.38 8 votes No rating yet
NegativeNeutralPositive

About company

Kura Oncology is a clinical-stage biopharmaceutical company based in San Diego that develops targeted small-molecule therapies for genetically defined cancers. The company focuses on precision oncology programs that inhibit key cancer drivers and DNA damage response or epigenetic mechanisms, advancing multiple candidates through clinical trials in both solid tumors and hematologic malignancies with the goal of securing regulatory approvals and commercializing successful products. Kura funds and manages clinical development, regulatory interactions and potential partnerships to bring its pipeline to market, and its common stock is traded on the Nasdaq.

Summarized from source with an LLMView SourceSector: Technology

Latest Results ():

Summarized from source with an LLMView Source

Key figures

41.1%1Y
-5.72%3Y
-66.9%5Y

Performance

60.2%1Y
63.2%3Y
61.3%5Y

Volatility

Market cap

801 M

Market cap (USD)

Daily traded volume (Shares)

872,786

Daily traded volume (Shares)

1 day high/low

8.65 / 8.425

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

3.38

8 votes
Performance:
starstarstarstarstar
3.63
Innovation:
starstarstarstarstar
3.38
Society:
starstarstarstarstar
3.25
Nature:
starstarstarstarstar
3.25
Yiling Guo
United Kingdom, 07 Nov 2025
star star star star star
Overall good
Man Huen Chloe Lam
United Kingdom, 07 Nov 2025
star star star star star
good performance
Misha Batvinov
United Kingdom, 03 Nov 2025
star star star star star
ok

EQUITIES OF THE SAME SECTOR

Meta Platforms Inc
Meta Platforms Inc Meta Platforms Inc Valor: 14917609
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
0.53%USD 667.21
BELIMO Holding Ltd
BELIMO Holding Ltd BELIMO Holding Ltd Valor: 110109816
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.69%CHF 721.00
International Game Technology PLC
International Game Technology PLC International Game Technology PLC Valor: 27140232
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.54%USD 12.85
Vertiv Holdings Co
Vertiv Holdings Co Vertiv Holdings Co Valor: 52408119
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.32%USD 322.43
Endava PLC
Endava PLC Endava PLC Valor: 42666274
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.30%USD 4.24
Elastic N.V.
Elastic N.V. Elastic N.V. Valor: 43878372
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.08%USD 47.83
Neogen Corp
Neogen Corp Neogen Corp Valor: 956244
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.94%USD 9.45
Cytokinetics Inc
Cytokinetics Inc Cytokinetics Inc Valor: 21533074
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-5.70%USD 61.60
Franklin Electric Co Inc
Franklin Electric Co Inc Franklin Electric Co Inc Valor: 931820
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.53%USD 103.50
Azenta Inc
Azenta Inc Azenta Inc Valor: 1568240
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-2.93%USD 25.15